Table 1 Demographic and clinical characteristics of patients

Gender, n (%)

0.109

0.628

0.198

0.628

0.198

 Female

18 (43.9)

2 (20.0)

4 (40.0)

4 (40.0)

8 (72.7)

 Male

23 (56.1)

8 (80.0)

6 (60.0)

6 (60.0)

3 (27.3)

Laterality, n (%)

0.183

0.650

0.080

0.350

0.198

 OD

24 (58.5)

5 (50.0)

7 (70.0)

8 (80.0)

4 (36.4)

 OS

17 (41.5)

5 (50.0)

3 (30.0)

2 (20.0)

7 (63.6)

Pain. n (%)

–

–

–

–

–

 No

41 (100.0)

10 (100.0)

10 (100.0)

10 (100.0)

11 (100.0)

VA (Pre/Post op), n (%)

0.997

1.000

1.000

0.812

1.000

 20/100

1 (2.4)

0 (0.0)

0 (0.0)

0 (0.0)

1 (9.1)

 20/100P

1 (2.4)

1 (10.0)

0 (0.0)

0 (0.0)

0 (0.0)

 20/200

2 (4.9)

1 (10.0)

0 (0.0)

0 (0.0)

1 (9.1)

 20/80

1 (2.4)

0 (0.0)

1 (10.0)

0 (0.0)

0 (0.0)

 CF 0.5M

4 (9.8)

1 (10.0)

1 (10.0)

1 (10.0)

1 (9.1)

 CF 1.0M

5 (12.2)

1 (10.0)

1 (10.0)

2 (20)

1 (9.1)

 CF 1.5M

1 (2.4)

0 (0.0)

1 (10.0)

0 (0.0)

0 (0.0)

 CF 2.0M

1 (2.4)

0 (0.0)

1 (10.0)

0 (0.0)

0 (0.0)

 HM

23 (56.1)

5 (50.0)

5 (50.0)

7 (70.0)

6 (54.5)

 LP

2 (4.9)

1 (10.0)

0 (0.0)

0 (0.0)

1 (9.1)

Hyperemia—pre, n (%)

–

–

–

–

–

 No

41 (100.0)

10 (100.0)

10 (100.0)

10 (100.0)

11 (100.0)

Hyperemia—post, n (%)

0.032

–

0.090

0.211

–

 Yes

3 (7.3)

0 (0.0)

0 (0.0)

3 (30.0)

0 (0.0)

 No

38 (92.7)

10 (100.0)

10 (100.0)

7 (70.0)

11 (100.0)

Phakic/Pseudophakic, n (%)

0.366

0.211

1.000

1.000

0.635

 Phakic

35 (85.4)

10 (100.0)

7 (70.0)

9 (90.0)

9 (81.8)

 Pseudophakic

6 (14.6)

0 (0.0)

3 (30.0)

1 (10.0)

2 (18.2)

Type of DM, n (%)

0.360

1.000

0.214

1.000

0.586

 DM 1

5 (12.2)

1 (10.0)

1 (10.0)

0 (0.0)

3 (27.3)

 DM 2

36 (87.8)

9 (90.0)

9 (90.0)

10 (100.0)

8 (72.7)

Insulin dependent. n (%)

0.038

1.000

0.670

0.057

0.149

 Yes

28 (68.3)

9 (90.0)

9 (90.0)

4 (40.0)

6 (54.5)

 No

13 (31.7)

1 (10.0)

1 (10.0)

6 (60.0)

5 (45.5)

A/NA, n (%)

–

–

–

–

–

 NA (non agitação)

20 (48.8)

10 (100.0)

10 (100.0)

0 (0.0)

0 (0.0)

 A (agitation)

21 (51.2)

0 (0.0)

0 (0.0)

10 (100.0)

11 (100.0)

SR/HSW, n (%)

–

–

–

–

–

 SR

20 (48.8)

10 (100.0)

0 (0.0)

10 (100.0)

0 (0.0)

 HSW

21 (51.2)

0 (0.0)

10 (100.0)

0 (0.0)

11 (100.0)

IOP pre

0.221^a

0.145^a

0.325^a

0.657^a

0.039^a

 Average (SD)

14.71 (3.32)

14.20 (3.65)

16.40 (2.76)

14.90 (3.28)

13.45 (3.27)

 Median (Min–Max)

15.00 (8.00–21.00)

13.50 (8.00–20.00)

16.00 (12.00–21.00)

15.50 (10.00–20.00)

14.00 (8.00–18.00)

 N

41

10

10

10

11

IOP post

0.581^a

0.450^a

0.468^a

0.594^a

0.437^a

 Average (SD)

13.71 (3.78)

13.60 (3.78)

14.90 (3.75)

12.50 (5.17)

13.82 (2.14)

 Median (Min–Max)

13.00 (4.00–20.00)

12.50 (8.00–19.00)

15.00 (10.00–20.00)

12.50 (4.00–20.00)

13.00 (10.00–18.00)

 N

41

10

10

10

11

Blood glucose

0.254^a

0.339^a

0.230^a

0.308^a

0.210^a

 Average (SD)

154.86 (68.24)

197.00 (112.03)

153.22 (54.28)

150.80 (51.67)

126.70 (33.13)

 Median (Min–Max)

141.00 (83.00–353.00)

175.00 (84.00–353.00)

141.00 (86.00–259.00)

139.00 (85.00–242.00)

138.00 (83.00–167.00)

N

37

8

9

10

10